Has Sandip Maru, MD received payments from drug or device companies?

Yes. Drug and device makers reported $54,203 in general payments to Sandip Maru, MD across 265 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sandip Maru, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sandip Maru, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sandip Maru, MD

Vascular Surgery · Holyoke, MANPI 1437314325

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 81.8% of it on its own, with 16 other manufacturers making up the rest. Among vascular surgery clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,203in general payments, 2019–2025

Across 265 payments — averaging $204.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$44K
Lemaitre Vascular, Inc.$3K
Endologix LLC$3K
Inari Medical, Inc.$2K
Stryker$625
Tactile Systems Technology Inc$605
plus $988 from 11 others

What the payments were for

Consulting fees$2,1574%
Speaking & faculty fees$29,14554%
Travel & lodging$11,23921%
Food & beverage$11,66222%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	120	$44,313
Lemaitre Vascular, Inc.	18	$2,860
Endologix LLC	12	$2,509
Inari Medical, Inc.	44	$2,304
Stryker	15	$625
Tactile Systems Technology Inc	39	$605
Bard Peripheral Vascular, Inc.	5	$339
W. L. Gore & Associates, Inc.	2	$309
Terumo Medical Corporation	1	$98
Cook Medical LLC	1	$84
E.r. Squibb & Sons, L.L.C.	2	$44
Penumbra, Inc.	1	$35
Siemens Medical Solutions USA, Inc.	1	$19
Smith+Nephew	1	$19
Baxter Healthcare	1	$18
Johnson & Johnson	1	$12
Cardiovascular Systems Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VenaSeal$28,539
HawkOne$5,902
ClosureFast$5,600
XENOSURE BIOLOGIC PATCH$2,157
FLOWTRIEVER CATHETER, S$1,697
CT THROMBECTOMY SYSTEM KIT$1,697
Alto Abdominal Stent Graft System$1,070
AFX2 Bifurcated Endograft System$937
GORE VIABAHN Endoprosthesis with Heparin$165
Abre$159
Venclose Maven Catheter$146
EXCLUDER Conformable AAA Endoprosthesis with Active Control$144
FlowTriever$137
IN.PACT Admiral$136
VALVULOTOM$129
Flexitouch Plus$127
ENTRE$127
ARTEGRAFT VASCULAR GRAFT$118
HYDRO LEMAITRE VALVULOTOME$108

How this compares

$54,203 in reported general payments places this provider in the 90th percentile of 142 vascular surgery providers in Massachusetts.

See all vascular surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$79,031

Medicare patients

220

Services billed

612

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	40	$820
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	22	$113

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Holyoke

Thomas OdonnellBoston$845K
Scott JamesPlymouth$199K
Anahita DuaBoston$186K
Dejah JudelsonWorcester$92K
Jonathan GertlerWeston$90K
Andres SchanzerWorcester$84K
Richard PinNorth Dartmouth$73K
Marc SchermerhornBoston$71K
Edwin GravereauxBoston$61K
Christopher KwolekBoston$55K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →